Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.

Abstract

BACKGROUND:

Five-year survival of patients with stage IV cancer of the fallopian tube is poor. Furthermore, patients with gynecological cancers presenting with a supraclavicular mass generally have an unfavorable prognosis.

CASE REPORT:

We describe a 70-year-old patient who presented with a left supraclavicular mass. The mass was removed and histology showed metastatic papillary adenocarcinoma strongly suggestive of papillary serous carcinoma. Abdominal hysterectomy and salpingo-oophorectomy showed a primary carcinoma of the fallopian tube. Postoperatively the patient received six cycles of carboplatin-based chemotherapy and is alive and well with no evidence of disease 5 years and 10 months after the primary diagnosis.

CONCLUSION:

Surgery and adjuvant carboplatin-based chemotherapy seem justified even in older patients with fallopian tube cancer and distant metastasis at the time of diagnosis.

• Authors: H S Scholz, S Lax, K F Tamussino, C Benedicic, E Petru
• Journal: Anticancer research (Anticancer Res) 2000 Nov-Dec Vol. 20 Issue 6C Pg. 4801-2 ISSN: 0250-7005 [Print] Greece
• PMID: 11205221 (Publication Type: Case Reports, Journal Article)

Chemical References

• Cyclophosphamide
• Carboplatin

Topics

• Adenocarcinoma, Papillary (drug therapy, pathology, surgery)
• Aged
• Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
• Carboplatin (administration & dosage)
• Chemotherapy, Adjuvant
• Clavicle
• Cyclophosphamide (administration & dosage)
• Fallopian Tube Neoplasms (drug therapy, pathology, surgery)
• Female
• Humans
• Hysterectomy
• Neoplasm Metastasis
• Ovariectomy
• Survivors
• Time Factors